↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Spain PLACE contract award · ocds-ted-734458-2024

Spain – Immunosuppressive agents – Adquisición de la especialidad farmacéutica TYSABRI 150 mg 1 ml jeringa precargada c/

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL awarded €391K to BIOGEN SPAIN, S.L. for Construction & Public Works in December 2024 — one of 245 awards this buyer has made, above its typical award size.

Construction & Public Works
02 Dec 2024
Award date
€391K
Contract value

Buying agency

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL
245 Awards
€404K Avg award
Above vs typical

Winning supplier

BIOGEN SPAIN, S.L.
77 Awards
36 Buyers
€45.1M Total won

Contract description

Spain – Immunosuppressive agents – Adquisición de la especialidad farmacéutica TYSABRI 150 mg 1 ml jeringa precargada c/2 (Natalizumab), con destino al Servicio de Farmacia, del Hospital Universitario Ramón y Cajal

Premium

Related awards · HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

245 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

201 more awards from this buyer · full history & CSV export

Premium

Other wins · BIOGEN SPAIN, S.L.

77 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL and BIOGEN SPAIN, S.L. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up